Bayesian Capital Management’s Enbridge ENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-54,700
Closed -$2.32M 710
2024
Q4
$2.32M Buy
+54,700
New +$2.29M 0.28% 100
2024
Q3
Sell
-78,519
Closed -$2.79M 780
2024
Q2
$2.79M Buy
+78,519
New +$2.8M 0.32% 78
2023
Q4
Sell
-61,517
Closed -$2.04M 828
2023
Q3
$2.04M Sell
61,517
-6,700
-10% -$238K 0.23% 110
2023
Q2
$2.53M Buy
68,217
+5,600
+9% +$213K 0.27% 91
2023
Q1
$2.39M Buy
62,617
+3,000
+5% +$118K 0.3% 94
2022
Q4
$2.33M Buy
+59,617
New +$2.33M 0.34% 47
2022
Q3
Sell
-18,419
Closed -$778K 786
2022
Q2
$778K Sell
18,419
-51,745
-74% -$2.31M 0.14% 215
2022
Q1
$3.23M Buy
+70,164
New +$3M 0.48% 29
2021
Q2
Sell
-8,700
Closed -$317K 475
2021
Q1
$317K Buy
+8,700
New +$306K 0.07% 339
2019
Q3
Sell
-16,100
Closed -$581K 564
2019
Q2
$581K Buy
16,100
+4,000
+33% +$146K 0.12% 233
2019
Q1
$439K Sell
12,100
-1,800
-13% -$64.9K 0.08% 318
2018
Q4
$432K Sell
13,900
-23,800
-63% -$765K 0.09% 319
2018
Q3
$1.22M Buy
37,700
+15,800
+72% +$552K 0.2% 137
2018
Q2
$782K Buy
+21,900
New +$694K 0.18% 155

Other funds holding ENB

Bayesian Capital Management's ENB Position: Q1 2025 in Review

Bayesian Capital Management sold out of Enbridge (ENB) in Q1 2025, closing a stake of 54,700 shares — an estimated $2.32M sold.

Bayesian Capital Management first reported a position in ENB in Q2 2018 and held it in 14 quarters. The position peaked at $3.23M in Q1 2022. 1,377 funds tracked by Wall St. Rank hold ENB as of Q1 2025.

  • Bayesian Capital Management reported no remaining Enbridge position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 54,700 Enbridge shares in Q1 2025, an estimated $2.32M.
  • Bayesian Capital Management first reported a position in Enbridge in Q2 2018 and held it in 14 quarters.
  • Bayesian Capital Management's Enbridge position peaked at $3.23M in Q1 2022.
  • 1,377 funds tracked by Wall St. Rank held Enbridge as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.